MedTrace Logo

Evaluation of Block Duration in Type 2 Diabetes Patients

NCT01704612 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2012-12-24

No results posted yet for this study

Summary

Diabete animal studies demonstrated a longer period recovery after local anesthetic injection (perineural administration). No clinical study demonstrated a prolonged nerve block duration in diabete type 2 patients after peripheral nerve block. The investigators hypothesized that block recovery is delayed in diabetic patients.

Conditions

  • Diabetes Type 2

Interventions

DRUG

ropivacaine

patients received 20 mL ropivacaine 5 mg/mL on subgluteal nerve

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    collaborator OTHER

  • Pierre and Marie Curie University

    lead OTHER

Principal Investigators

  • Philippe Cuvillon, PhD · APHP Pitié Salpetriere

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01704612 on ClinicalTrials.gov